Back to Journals » Journal of Hepatocellular Carcinoma » Volume 4

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Total article views   HTML views PDF downloads Totals
25,830 Dovepress* 22,616+ 1,434 24,050
PubMed Central* 3,214 312 3,526
Totals 25,830 1,746 27,576
*Since 12 April 2017
Total mentioned Facebook Delicious Reddit Twitter Others
309 0 0 0 4 305

View citations on PubMed Central and Google Scholar